Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor.

Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor.

Item
http://www.wikidata.org/entity/Q44193574
H435-containing immunoglobulin G3 allotypes are transported efficiently across the human placenta: implications for alloantibody-mediated diseases of the newborn.Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europeII Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies.Clinical experience with an L-proline–stabilized 10 %intravenous immunoglobulin (Privigen®): real-life effectiveness and tolerability.Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency.IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID.Improved outcomes on subcutaneous IgG in patients with humoral immunodeficiency and co-morbid bowel diseaseInfluence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies.Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.Immunoglobulin replacement therapy for primary immunodeficiencies.The multiple facets of FcRn in immunity.Bevacizumab Pharmacokinetics Influence Overall and Progression-Free Survival in Metastatic Colorectal Cancer Patients.FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors.Therapeutic immunoglobulin should be dosed by clinical outcome rather than by body weight in obese patients.Pharmacokinetics of Monoclonal Antibodies.Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS.Eosinophilic gastroenteritis in a patient with Bruton's tyrosine kinase deficiency.
P2860

Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor.

Item
http://www.wikidata.org/entity/Q44193574
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Efficiency of immunoglobulin G ...... m of the neonatal Fc receptor.
@en
Efficiency of immunoglobulin G ...... m of the neonatal Fc receptor.
@nl
type
label
Efficiency of immunoglobulin G ...... m of the neonatal Fc receptor.
@en
Efficiency of immunoglobulin G ...... m of the neonatal Fc receptor.
@nl
prefLabel
Efficiency of immunoglobulin G ...... m of the neonatal Fc receptor.
@en
Efficiency of immunoglobulin G ...... m of the neonatal Fc receptor.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Efficiency of immunoglobulin G ...... m of the neonatal Fc receptor.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932